The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDci Advisors Regulatory News (DCI)

Share Price Information for Dci Advisors (DCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.70
Bid: 4.50
Ask: 4.90
Change: 0.00 (0.00%)
Spread: 0.40 (8.889%)
Open: 4.75
High: 4.75
Low: 4.70
Prev. Close: 4.70
DCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on legal actions

13 Dec 2023 08:46

RNS Number : 6335W
DCI Advisors Limited
13 December 2023
 

DCI Advisors Limited

(the "Company")

 

 

Update on legal actions with Dolphin Capital Partners Limited ("DCP")

 

13 December 2023

 

The Board of DCI Advisors Ltd ("DCI" or the "Company") provides the following update on all current legal disputes between the Company and its former Investment Manager, DCP, and DCP's close business partners. The background for these legal disputes is that the Company terminated the Investment Management Agreement dated 1 December 2021 (the "IMA") between the Company and DCP on 20 March 2023 on the basis of a repudiatory breach of contract by DCP for failing to disclose a share option contract in relation to the sale of the Amanzoe resort in 2018 (the "Undisclosed Share Option Agreement").

 

1. The most recent development is the filing of criminal charges in Greece by DCI against Miltos Kambourides, Michael Tsirikos, and some members of staff of DCP and DCP's close business partner Zoniro SA in Greece. These criminal charges were filed on 12 December 2023, and involve allegations of money laundering, and the abuse of corporate governance. In total 9 individual cases were filed as part of these criminal charges.

 

2. In August 2023, DCP's close business partner Zoniro Ltd issued a statutory demand claiming that certain sums were payable to it by DCI and another DCI group company. As background, Zoniro SA (until 2015 part of DCI) used to be DCI's project development manager for its Greek assets until the termination of the agreements with Zoniro by DCI for suspected misconduct. DCI has issued proceedings in the Commercial Court in the BVI to formally set aside the two statutory demands, and has explained in its court filings the close relationship between DCP and Zoniro and evidence of collusion between the two to cause harm to DCI. Zoniro has not responded to DCI's proceedings, and is now out of time to do so, suggesting that it has no answer to the allegations set out in DCI's evidence. A hearing is scheduled to be held in the BVI Court in February 2024 when the matter will be determined. Until that time, we do not expect any material developments in those proceedings. Zoniro also started legal proceedings against one of DCI's subsidiaries in Greece, and the Greek affiliate is defending the case vigorously.

 

3. In early April 2023, DCP filed a claim in the High Court of Justice of England and Wales against DCI alleging a repudiatory breach of contract by the Company in relation to the termination of the IMA (the "Commercial Claim") and claiming for unpaid fees. The Company considers the Commercial Claim to be opportunistic, and without merit and is defending it vigorously. The Company filed its defence and counterclaim in June 2023, and it has also applied to accelerate the matter by filing a reverse summary judgment / strike out application to summarily determine the principal points of each party's claims and counterclaims. The reverse summary judgment hearing is scheduled to be held in March 2024.

As the above actions show, the Company will pursue all legal options to defend itself and recover the value arising from the Undisclosed Share Option Agreement and damages from other cases. The directors continue to believe that the value of the Undisclosed Share Option Agreement could be material in the context of the size of the Company, but at this time they are not in a position to be able to put a precise quantum on the Undisclosed Share Option. No accrual has therefore been made in the Company's financial accounts although the costs of all legal actions are accrued as they are incurred.

 

Enquiries

DCI Advisors Ltd

Nicolai Huls / Nick Paris, Managing Directors

 

nickparis@btinternet.com

+44 (0) 7738 470550

Cavendish Capital Markets (Nominated Adviser & Broker)

William Marle / Jonny Franklin-Adams / Edward Whiley / (Corporate Finance)

Pauline Tribe (Sales)

 

 

+44 (0) 20 7220 0500

FIM Capital Limited (Administrator)

Lesley Lennon / Grainne Devlin (Corporate Governance)

llennon@fim.co.im / gdevlin@fim.co.im

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDTJBPTMTIBMFJ
Date   Source Headline
15th Nov 20162:05 pmRNSSecond Price Monitoring Extn
15th Nov 20162:00 pmRNSPrice Monitoring Extension
15th Nov 20167:00 amRNSDisposal
25th Oct 20167:00 amRNSPosting of Half Yearly Report
30th Sep 20167:00 amRNSHalf-year Report
23rd Sep 20167:00 amRNSNotice of Results
19th Jul 20169:23 amRNSDirector Declaration - Additional Directorship
19th Jul 20167:00 amRNSAppointment of Non-Executive Director
15th Jul 20163:06 pmRNSDirector/PDMR Shareholding
5th Jul 20165:00 pmRNSDirector/PDMR Shareholding
30th Jun 20167:00 amRNSFinal Results
21st Mar 20164:35 pmRNSPrice Monitoring Extension
1st Mar 20163:37 pmRNSDirectorate Change
1st Mar 20163:34 pmRNSDirectorate Change
11th Feb 20167:00 amRNSQ4 2015 Trading Update
10th Feb 20164:40 pmRNSSecond Price Monitoring Extn
10th Feb 20164:35 pmRNSPrice Monitoring Extension
28th Jan 20168:24 amRNSNotice of Q4 2015 Trading Update
30th Dec 20157:00 amRNSRetirement of Director
20th Oct 20157:00 amRNSPosting of Half Yearly Report
12th Oct 20157:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
7th Oct 201510:25 amRNSReplacement: Holding(s) in Company
7th Oct 20159:38 amRNSHolding(s) in Company
6th Oct 20157:00 amRNSAppointment of Andrew Coppel CBE to Board
25th Sep 20153:41 pmRNSHolding(s) in Company
24th Sep 20157:00 amRNSHalf Yearly Report
15th Sep 20157:00 amRNSNotice of Results
30th Jul 20157:01 amRNSQ2 Trading Update
8th Jul 20159:00 amRNS2014 Annual Report and Accounts
30th Jun 20157:00 amRNSUpdate re capital controls measures in Greece
16th Jun 201512:40 pmRNSHolding(s) in Company
15th Jun 20152:34 pmRNSHolding(s) in Company
11th Jun 20155:05 pmRNSHolding(s) in Company
11th Jun 20155:02 pmRNSHolding(s) in Company
11th Jun 20155:00 pmRNSHolding(s) in Company
11th Jun 20154:59 pmRNSHolding(s) in Company
11th Jun 20158:00 amRNSAdmission of new Shares
5th Jun 20155:37 pmRNSPASSING OF WRITTEN RESOLUTION
4th Jun 20158:00 amRNSResults of Placing Announcement
3rd Jun 20157:00 amRNSProposed Issue of New Shares to raise EUR75 m
3rd Jun 20157:00 amRNSFinal Results
25th Feb 20157:02 amRNSDirectorate Changes and Review of Strategy
18th Feb 201511:09 amRNSHolding(s) in Company
4th Dec 20147:00 amRNSQ3 Trading Update
27th Nov 20149:00 amRNSNotice of Results
12th Nov 20147:00 amRNSClosing of $30.5m investment into Playa Grande
23rd Oct 20148:00 amRNSPosting of Half Yearly Report
23rd Sep 20147:00 amRNSHalf Yearly Report
12th Sep 201411:37 amRNSNotice of Results
8th Aug 20147:00 amRNSClosing of Investment into Amanzoe

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.